EUVIMEDEUVIMED entdecken
Open Access

Clinical outcomes of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization

Deepshekhar Gupta, Yunjuan Liu, Chris Miller-Rosales, Fangzhou Wei, Edward Tuttle, Ekaterina Byers, Richard Marshak, Richard Marshall

Journal of Comparative Effectiveness Research · 2026-05 · 15 (5)

DOI: 10.57264/cer-2025-0144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2026-05. Verfasst von Deepshekhar Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Analysis Group, Inc., Menlo Park, CA, 94025, USA. Hauptthemen laut MEDLINE: Radioembolization, Therapeutic, Liver Neoplasms, Chemoembolization, Therapeutic, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Prior research observed that pressure-enabled drug delivery (PEDD) counteracts intra-tumoral pressure during trans-arterial chemoembolization (TACE) and radioembolization (TARE), improving drug penetration, yet real-world evidence remains limited. This study examined outcomes associated with PEDD use, including in high-adopter facilities, and assessed potential cost avoidance associated with PEDD. Materials & methods: We used the Clarivate Real World Data repository to identify adults with hepatocellular carcinoma or secondary liver metastases who received TACE or TARE procedures (January 2020–March 2024). We compared baseline characteristics between PEDD and non-PEDD cohorts, then used a two-stage matching approach to develop a matched sample for comparative analyses. Facilities in the top fifth percentile of PEDD volume were examined separately.

Results

In total, 603 PEDD and 16,210 non-PEDD patients were identified. PEDD patients had higher baseline disease burden on average. In matched analyses, PEDD was associated with reduced rates of fatigue overall (20.9% vs 26.4%, p < 0.05) and 30-day inpatient visits among patients receiving TACE procedures (8.0% vs 20.5%, p < 0.05). In high-adopter facilities, PEDD use was associated with reduced lymphopenia among all patients (0.6% vs 5.2%, p < 0.05) and reduced fatigue (19.2% vs 39.7%, p < 0.05) and lymphopenia (0.0% vs 8.2%, p < 0.05) among patients with secondary liver metastases. PEDD use was linked to a per-patient charge avoidance of $7734 through fewer complications ($4599) and inpatient stays ($3135).

Conclusion

Despite greater patient comorbidity, PEDD use was associated with fewer post-procedure complications and lower healthcare resource utilization. Greater institutional experience may enhance patient outcomes. Reduced complications and hospitalizations can translate into cost avoidance, reinforcing the value of PEDD technology in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radioembolization, TherapeuticLiver NeoplasmsChemoembolization, TherapeuticCarcinoma, HepatocellularDrug Delivery SystemsHumansFemaleMaleMiddle AgedAgedPressureTreatment Outcome

Stichwörter der Autor:innen

hepatocellular carcinomalocoregional therapymedical devicepressure-enabled drug deliveryreal-world evidence

Autor:innen und Institutionen

  • Analysis Group, Inc., Menlo Park, CA, 94025, USA.
  • TriSalus Life Sciences, Inc., Westminster, CO, 80031, USA.
  • Tulane University, School of Medicine, New Orleans, LA, 70112, USA.

Zitieren

APA

Gupta, D., Liu, Y., Miller-Rosales, C., Wei, F., Tuttle, E., Byers, E., Marshak, R., & Marshall, R. (2026). Clinical outcomes of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization. Journal of Comparative Effectiveness Research, 15(5). https://doi.org/10.57264/cer-2025-0144

Vancouver

Gupta D, Liu Y, Miller-Rosales C, Wei F, Tuttle E, Byers E, et al. Clinical outcomes of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization. Journal of Comparative Effectiveness Research. 2026;15(5). doi:10.57264/cer-2025-0144

BibTeX
@article{Gupta2026,
  author = {Gupta, Deepshekhar and Liu, Yunjuan and Miller-Rosales, Chris and Wei, Fangzhou and Tuttle, Edward and Byers, Ekaterina and Marshak, Richard and Marshall, Richard},
  title = {Clinical outcomes of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.57264/cer-2025-0144}
}
Kostenlos starten →